Co-Chairs’ Opening Remarks and Recap of Day One
April 30, 2019 • 8:00 am
The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Challenges
April 30, 2019 • 1:00 pm
A Town Hall with the Magistrate Judges*
April 30, 2019 • 9:15 am
The Great Debate with District Judges
April 29, 2019 • 5:15 pm
VIEW FROM THE FEDERAL CIRCUIT
April 29, 2019 • 10:30 am
Antitrust Developments Concerning Brands & Generics
April 30, 2019 • 11:30 am
Latest FDA Initiatives Affecting Generic Drug Access and Pricing
April 30, 2019 • 8:15 am
Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum
April 29, 2019 • 4:15 pm
ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*
April 29, 2019 • 2:00 pm
The Business of Pharmaceutical Patent Litigation: A Global Approach
New Developments in Market Access and Exclusivities
The Practice of Pharmaceutical Patent Litigation: Part II
The Evolving Induced Infringement Analysis
April 30, 2019 • 3:15 pm
The Ethical Practice of Paragraph IV Litigation: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena
April 30, 2019 • 4:00 pm
The Practice of Pharmaceutical Patent Litigation: Part I
The Costs and the Consequences of Determining Venue Post-TC Heartland
April 29, 2019 • 1:00 pm
Assessing Secondary Considerations in Light of Blocking Patents Post-Acorda
April 30, 2019 • 2:00 pm
Addressing the Impact of a Uniform Claims Construction Standard: Panacea or Peril?
April 29, 2019 • 9:15 am
Parallel Proceedings Master Class
May 1, 2019 • 1:00 pm
The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses
April 29, 2019 • 8:15 am
The Supreme Court Weighs in on the On- Sale Bar and the State of Secret Prior Art
April 29, 2019 • 11:00 am
Working Group on Biosimilars for the Hatch-Waxman Practitioner
May 1, 2019 • 8:30 am
Receive exclusive discounts, offers and agenda updates directly to your inbox.